Clinical trial

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or…

NCT00499733 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other · Terminated

Key facts

NCT number NCT00499733
Title Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer
Official title Sequential Administration of Cryoablation and Cyclophosphamide for Advanced Solid Epithelial Cancer
Lead sponsor Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other
Collaborators National Cancer Institute (NCI) NIH
Status Terminated
Phase Early Phase 1
Study type Interventional
Conditions Cancer
Intervention type Device, Drug
Interventions cyclophosphamide, Cryoablation
Enrollment 19
Start date Jun 1, 2007
Primary completion Jul 1, 2010
Completion Jan 9, 2013
First posted Jul 11, 2007
Last update posted Jan 18, 2019
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies